Literature DB >> 18217225

Human immunodeficiency virus viral load in blood plasma and semen: review and implications of empirical findings.

Seth C Kalichman1, Giorgio Di Berto, Lisa Eaton.   

Abstract

The majority of human immunodeficiency virus (HIV) infections in the world are sexually transmitted and quantities of HIV in genital fluids are an important transmission risk-determining factor. Estimating men's sexual HIV infectiousness from blood viral load hinges on the association between HIV in blood plasma (BPVL) and semen viral load (SVL). This article reviews research on the association between BPVL and SVL as reported in 19 empirical studies (N = 1226). Findings yielded a mean correlation between BPVL and SVL of 0.45 (SD = 0.20, median = 0.45, range = 0.07-.64). SVL was generally lower than BPVL, but this pattern was variable across studies. Co-occurring sexually transmitted infections (urethritis), nonsuppressive HIV treatments, and drug resistance account for the variability in observed correlations. HIV disease progression does not reliably influence the association between BPVL and SVL. Research is needed to determine the degree to which BPVL as well as SVL predict HIV transmission.

Entities:  

Mesh:

Year:  2008        PMID: 18217225     DOI: 10.1097/olq.0b013e318141fe9b

Source DB:  PubMed          Journal:  Sex Transm Dis        ISSN: 0148-5717            Impact factor:   2.830


  65 in total

1.  Herpes viruses and HIV-1 drug resistance mutations influence the virologic and immunologic milieu of the male genital tract.

Authors:  Sara Gianella; Sheldon R Morris; Christy Anderson; Celsa A Spina; Milenka V Vargas; Jason A Young; Douglas D Richman; Susan J Little; Davey M Smith
Journal:  AIDS       Date:  2013-01-02       Impact factor: 4.177

2.  Raltegravir penetration in seminal plasma of healthy volunteers.

Authors:  Andrea Calcagno; Stefano Bonora; Antonio D'Avolio; Marco Siccardi; Marco Simiele; Mattia Chiesa; Daniel Gonzalez de Requena; Giovanni Di Perri
Journal:  Antimicrob Agents Chemother       Date:  2010-03-22       Impact factor: 5.191

3.  Beliefs about treatments for HIV/AIDS and sexual risk behaviors among men who have sex with men, 1997-2006.

Authors:  Seth C Kalichman; Lisa Eaton; Denise White; Charsey Cherry; Howard Pope; Demetria Cain; Moira O Kalichman
Journal:  J Behav Med       Date:  2007-08-10

4.  Mobile Health Intervention to Reduce HIV Transmission: A Randomized Trial of Behaviorally Enhanced HIV Treatment as Prevention (B-TasP).

Authors:  Seth C Kalichman; Chauncey Cherry; Moira O Kalichman; Lisa A Eaton; James J Kohler; Catherine Montero; Raymond F Schinazi
Journal:  J Acquir Immune Defic Syndr       Date:  2018-05-01       Impact factor: 3.731

Review 5.  Risk compensation in HIV prevention: implications for vaccines, microbicides, and other biomedical HIV prevention technologies.

Authors:  Lisa A Eaton; Seth Kalichman
Journal:  Curr HIV/AIDS Rep       Date:  2007-12       Impact factor: 5.071

Review 6.  Antiretroviral therapy: a key component of a comprehensive HIV prevention strategy.

Authors:  Mark W Hull; Julio Montaner
Journal:  Curr HIV/AIDS Rep       Date:  2011-06       Impact factor: 5.071

7.  Integrated behavioral intervention to improve HIV/AIDS treatment adherence and reduce HIV transmission.

Authors:  Seth C Kalichman; Chauncey Cherry; Moira O Kalichman; Christina M Amaral; Denise White; Howard Pope; Connie Swetzes; Lisa Eaton; Rene Macy; Demetria Cain
Journal:  Am J Public Health       Date:  2011-01-13       Impact factor: 9.308

Review 8.  A strategy for selecting sexual partners believed to pose little/no risks for HIV: serosorting and its implications for HIV transmission.

Authors:  Lisa A Eaton; Seth C Kalichman; Daniel A O'Connell; William D Karchner
Journal:  AIDS Care       Date:  2009-10

9.  HIV transmission risk among HIV seroconcordant and serodiscordant couples: dyadic processes of partner selection.

Authors:  Lisa A Eaton; Tessa V West; David A Kenny; Seth C Kalichman
Journal:  AIDS Behav       Date:  2008-10-25

10.  Persistent genital tract HIV-1 RNA shedding after change in treatment regimens in antiretroviral-experienced women with detectable plasma viral load.

Authors:  Kartik K Venkatesh; Allison K DeLong; Rami Kantor; Stacey Chapman; Jessica Ingersoll; Jaclynn Kurpewski; Maria Pia De Pasquale; Richard D'Aquila; Angela M Caliendo; Susan Cu-Uvin
Journal:  J Womens Health (Larchmt)       Date:  2013-03-26       Impact factor: 2.681

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.